GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adynxx Inc (FRA:HL1C) » Definitions » EV-to-FCF

Adynxx (FRA:HL1C) EV-to-FCF : -3.37 (As of Jun. 12, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Adynxx EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Adynxx's Enterprise Value is €20.57 Mil. Adynxx's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2019 was €-6.10 Mil. Therefore, Adynxx's EV-to-FCF for today is -3.37.

The historical rank and industry rank for Adynxx's EV-to-FCF or its related term are showing as below:

FRA:HL1C's EV-to-FCF is not ranked *
in the Biotechnology industry.
Industry Median: 8.21
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-12), Adynxx's stock price is €3.00. Adynxx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was €-2.221. Therefore, Adynxx's PE Ratio for today is At Loss.


Adynxx EV-to-FCF Historical Data

The historical data trend for Adynxx's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adynxx EV-to-FCF Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.08 -6.19 -5.86 -4.63 -5.17

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Adynxx's EV-to-FCF

For the Biotechnology subindustry, Adynxx's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adynxx's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adynxx's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Adynxx's EV-to-FCF falls into.



Adynxx EV-to-FCF Calculation

Adynxx's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=20.574/-6.1
=-3.37

Adynxx's current Enterprise Value is €20.57 Mil.
Adynxx's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adynxx  (FRA:HL1C) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Adynxx's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.00/-2.221
=At Loss

Adynxx's share price for today is €3.00.
Adynxx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.221.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Adynxx EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Adynxx's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adynxx (FRA:HL1C) Business Description

Traded in Other Exchanges
N/A
Address
100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.

Adynxx (FRA:HL1C) Headlines

No Headlines